Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-16

FDA Approved: SEVOFLURANE — Supplemental Application (Piramal Critical Care Inc)

View source ↗

Summary

The FDA approved a supplemental application for Sevoflurane from Piramal Critical Care Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sevoflurane (Sevoflurane)

Snippet

SUPPL AP for SEVOFLURANE (SEVOFLURANE)